Health Condition 1: C00-D49- Neoplasms
Conditions
Interventions
Intervention1: Nil: Nil
Sponsors
Torrent Pharmaceuticals Ltd.
Eligibility
Inclusion criteria
Inclusion criteria: 1. Adults aged more than 18 years. 2. Histologically or cytologically confirmed solid tumors 3. Received S-1 monotherapy or combination therapy for at least one cycle during the study period 4. Availability of clinical documentation or retrospective Patient-Reported Outcomes (PRO) data for baseline and follow-up.
Exclusion criteria
Exclusion criteria: 1. Diagnosis of haematological malignancy 2. Participation in an interventional clinical trial involving S-1 during the study period 3. Incomplete or missing treatment data at baseline and follow-up. 4. Pregnancy/lactation during therapy.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Drug utilization trend of S1 therapy by Tumour type 2. Assessment of line of therapy, intent of treatment, dosing & frequency of S1 therapyTimepoint: Baseline | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Median duration of S-1 treatment in real-world settings 2. Incidence and type of adverse events (AEs)Timepoint: Baseline | — |
Countries
India
Contacts
Public ContactDr Rathish Nair
Torrent Pharmaceuticals Ltd.
Outcome results
None listed